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Background: Several studies have indicated that human pre-implantation embryo-derived chorionic gonadotropin
(hCG) may influence the implantation process by its action on human endometrial epithelial and stromal cells.
Despite reports indicating that hCG acts on these cells to affect the production of several cytokines and growth
factors (e.g., MIF, IGF-I, VEGF, LIF, IL-11, GMCSF, CXL10 and FGF2), our understanding of the integral influence of
hCG on paracrine interactions between endometrial stromal and epithelial cells during implantation is very limited.
Methods: In the present study, we examined the profile of 48 cytokines in the conditioned media of primary cell
cultures of human implantation stage endometrium. Endometrial epithelial cells (group 1; n = 20), stromal cells (group
2; n = 20), and epithelial plus stromal cells (group 3; n = 20) obtained from mid-secretory stage endometrial samples
(n = 60) were grown on collagen and exposed to different doses (0, 1, 10 and 100 IU/ml) of rhCG for 24 h in vitro.
Immunochemical and qRT-PCR methods were used to determine cytokine profiles. Enrichment and process networks
analyses were implemented using a list of cytokines showing differential secretion in response to hCG.
Results: Under basal conditions, endometrial epithelial and stromal cells exhibited cell type-specific profiles of secreted
cytokines. Administration of hCG (100 IU) resulted in significantly (P < 0.05) different cytokine secretion profiles indicative
of macropinocytic transport (HGF, MCSF) in epithelial cells, signal transduction (CCL4, FGF2, IL-1b, IL-6, IL-17, VEGF) in
stromal cells, and epithelial-mesenchymal transition (FGF2, HGF, IL-1b, TNF) in mixed cells. Overall, the administration
of hCG affected cytokines involved in the immune response, chemotaxis, inflammatory changes, proliferation, cell adhesion
and apoptosis.
Conclusions: CG can influence the function of the endometrium during blastocyst implantation via its differential action
on endometrial epithelial and stromal cells. CG may also affect complex paracrine processes in the different endometrial
cell types.
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Blastocyst implantation in humans involves a complex
process that occurs during the mid-luteal phase of the
menstrual cycle when the maternal endometrium be-
comes receptive and the blastocyst becomes free of the
zona pellucida and invades the endometrium. There is* Correspondence: debabrata.ghosh1@gmail.com
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reproduction in any medium, provided the orsubstantial evidence to suggest that mutual interaction
between pre-implantation stage endometrium and the
embryo plays a critical role in this process [1]. One of
the factors that may potentially influence the biology of
the peri-implantation stage endometrium is human
chorionic gonadotropin (hCG) [1], which may be se-
creted by the human pre-implantation embryo [2,3] and
implantation-stage human endometrium [4,5]. This se-
cretion profile of hCG is supported by the observation
that in the secretory phase, epithelial and stromal cellsral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Srivastava et al. Reproductive Biology and Endocrinology 2013, 11:116 Page 2 of 15
http://www.rbej.com/content/11/1/116from the human endometrium express receptors for
hCG [6,7]. Furthermore, it has been demonstrated that
the administration of hCG can influence endometrial
functions in various experimental models [7-13].
Our understanding of the integral influence of hCG in
paracrine interactions between endometrial stromal and
epithelial cells during implantation is limited. In a recent
study, Paiva et al. [14] examined the effect of hCG (0.2,
2 and 20 IU/ml) administered to human endometrial
epithelial cells in vitro and observed that recombinant
hCG stimulated the secretion of six analytes (VEGF, LIF,
IL-11, GMCSF, CXL10 and FGF2). However, hCG acts
on human endometrial stromal cells to promote a var-
iety of functions that include stimulation of production
of the multi-functional cytokine, macrophage inhibitory
factor (MIF) [9], suppression of the cellular apoptotic
machinery [15,16], and reduction in insulin-like growth
factor-I (IGF-I) and interferon-gamma-mediated respon-
siveness of stromal decidual cells [11,17]. Nonetheless,
the responsiveness of human endometrial stromal cells
and epithelial cells to hCG remains undefined mainly for
two reasons. First, the endometrial cells used in previous
studies were grown on a conventional two-dimensional
plastic substratum, which typically fails to support a
physiological phenotype. Several studies have indicated
that a three-dimensional culture system is a better
model in this regard [18-20]. Also, the integral influence
of paracrine interactions between stromal and epithelial
cells in mediating hCG effects has not been reported
[20]. In the present study, we addressed these issues
through the multi-analyte profiling of 48 cytokines,
chemokines and growth factors. The secretion of these
factors was assessed in the conditioned media of three-
dimensional primary cell cultures of human endomet-
rial epithelial cells, stromal cells, and epithelial plus
stromal cells isolated from endometrial biopsies col-
lected during the ‘window’ of implantation. These cell
types were grown on collagen-I biomatrix and exposed
to different doses of hCG. The cytokines, chemokines
and growth factors investigated in the study have been
previously reported to be synthesised and secreted by
the human endometrium [21].
Methods
Patients and tissue collection
This study was approved by the Ethics Committee of the
All India Institute of Medical Sciences (AIIMS) and con-
ducted in accordance with the Helsinki Declaration.
Sixty pre-menopausal women (mean age: 28 ± 4 years;
BMI: 18.9-22.8 kg/m2) with regular menstrual cycles
(30 ± 2 days) attending the out-patient fertility clinic of
the Department of Obstetrics and Gynaecology, AIIMS,
were selected for the present study. The women under-
went dilation and curettage to collect endometrial tissuesamples for diagnostic gynaecological procedures and
were a priori screened to determine whether they were
negative for pregnancy and tuberculosis. Also, these
women had not received any steroid treatment for at
least 4 months prior to tissue collection and were not
suffering from any endocrine disorder or systemic dis-
ease. Randomly chosen pieces of sample were pro-
vided to us, and all women provided written informed
consents to participate in the study. The tissue sam-
ples were collected on ice in sterile DMEM:F12 (1:1)
medium containing 5% (v/v) FCS, gentamicin (10 μg/ml),
penicillin (100 IU/ml), streptomycin (100 μg/ml) and
fungizone (2.5 μg/ml) and were immediately trans-
ported on ice to the cell culture laboratory for further
processing.
Each fresh specimen was washed three times in ice-
cold sterile HBSS supplemented with antibiotics and an
antimycotic agent to remove blood and secretions and
were randomly divided into two parts. One small section
was washed in phosphate buffer saline (pH 7.4) and
fixed in ice-cold neutral buffered paraformaldehyde
(4% w/v), pH 7.4, for histological assessment, and the re-
sidual tissue was processed for tissue dissociation and
cell separation as described below.
Cell isolation and separation
Enzymatic dissociation of endometrial tissue followed by
cell separation was performed using previously described
standardised procedures [19,22,23]. Briefly, the endomet-
rial specimen was washed in HBSS, minced and incubated
at 37°C with collagenase III (0.2%, w/v) in HBSS supple-
mented with 2% (v/v) foetal calf serum (FCS), 15 mM
HEPES (N-2-hydroxyethyl-piperazine-N’-2-ethanesulfonic
acid), 1X antibiotic-antimycotic solution [penicillin
(100 IU/ml), streptomycin (100 μg/ml) and fungizone
(2.5 μg/ml)] and gentamicin (10 μg/ml) for 30 minutes
with shaking at 50 rpm. The final cell suspension
contained primarily single stromal cells and fragments of
glands. The cell suspension was washed three times with
Ca++/Mg++-free HBSS supplemented with the antibiotic/
antimycotic mixture (HBSS-mod) and filtered through a
sterile, pre-equilibrated mesh filter (51 μm). The filtrate
contained the ‘stromal cell enriched’ fraction. The residual
‘epithelial cell enriched’ fraction was further purified by
unit gravity sedimentation in 10% (v/v) FBS. The stromal
cells remained in cell suspension, and the sediment,
consisting of sheets, fragments and clumps of epithe-
lial cells, was collected and washed three times with
HBSS-mod. The ‘epithelial cell fraction’ was further
enriched by density-dependent fractionation on a dis-
continuous Percoll gradient as described previously
[19,22,23]. The ‘epithelial cell enriched fraction’ was re-
suspended in complete medium (DMEM:F12 with 10%
FCS) and stored on ice.
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by density-dependent fractionation on a discontinuous
Percoll gradient as described previously [19,22,23]. CD45-
positive leucocytes were depleted using anti-CD45 MACS
microbeads and LS magnetic separation columns in a
MidiMACS separator (Miltenyi Biotec, Bergisch Gladbach,
Germany) as described [24]. The negative fraction con-
taining the stromal cell-enriched population was washed
twice with HBSS-mod at 300 × g for 10 minutes and re-
suspended in 1 ml of complete medium (DMEM:F12 with
10% FCS) and kept on ice. For separated mixed cells, endo-
metrial cells separated by enzymatic digestion were not
passed through a mesh filter, but the remaining steps were
followed as described above. The yield and viability of the
isolated cells were determined using standard proto-
cols [24]. The relative abundance of cytokeratin-positive,
vimentin-positive, CD45-positive and vW factor-positive
cells in all three groups was determined using standard
immunocytochemical procedures [25].
Primary culture of human endometrial cells
Primary cell cultures at 1x105 cells/cm2 were separated
into three different groups: Group 1: epithelial cells (n =
20), Group 2: stromal cells (n = 20), and Group 3: mixed
cells (n = 20). All three groups were cultured in DMEM:
F12 (1:1) medium containing 10% (v/v) FCS, gentamicin
(10 μg/ml), penicillin (100 IU/ml), streptomycin (100 μg/ml)
and fungizone (2.5 μg/ml) in a 5% CO2 atmosphere at 37°C
on rat-tail collagen type I as described previously [19,22,23].
Briefly, rat-tail collagen was extracted from tendon bundles
of sterilised rat tails in sterile diluted (1:1,000) acetic acid at
4°C, and the acid-soluble collagen (2.0 ± 0.2 mg/ml) was col-
lected aseptically and used as stock as previously described
[19,22]. Collagen biomatrix was generated by neutralising
acid collagen with 0.34 N NaOH and diluted with 10X
medium to a concentration of 1.2 ± 0.1 mg/ml at pH 7.4 on
ice and then gelled at 37°C with 5% carbon dioxide [19,22].
Cells were allowed to attach with a daily change of medium;
at 72 hours when cells had grown to ≈ 80% confluence,
serum-free DMEM:F12 (1:1) medium supplemented
with insulin (10 μg/ml), transferrin (5.5 μg/ml), selen-
ium (6.7 ng/ml), hydrocortisone (5 μg/ml), gentamicin
(10 μg/ml), penicillin (100 IU/ml), streptomycin (100 μg/ml)
and fungizone (2.5 μg/ml) (designated as basal condition)
was added. Serum-free cell cultures in all three groups were
exposed to different concentrations (0, 1, 10, 100 IU/ml) of
rhCG in triplicate. After 24 hours, cultures were terminated,
and gels containing cells were used for RNA extraction and
quantitative gene expression using RT-PCR. The remaining
conditioned media were collected and centrifuged at
10,000 × g for 5 minutes, and the supernatant was stored at
−80°C for immunoassay of multiple cytokines and immuno-
blotting experiments. Five replicates in duplicate were con-
ducted for each set of experiments.hCG binding to isolated endometrial cells
Different sets (n = 3) of experiments were performed to
examine the binding of biotinylated rhCG to the cells
grown in culture. Biotin labelling of hCG was performed
using a commercially available biotin labelling kit from
Thermo Scientific (Rockford, IL, USA) according to the
manufacturer’s protocol. Isolated endometrial cells were
grown separately on collagen-coated cover slips in
DMEM:F12 complete medium as described above. The
cells were then washed twice in serum-free DMEM:F12
and exposed to biotinylated rhCG (200 mIU/ml) at 37°C
in a humidified incubator with 5% CO2 for 40 minutes;
these parameters were determined based on initial op-
timisation with three concentrations (100, 200 and
400 mIU/ml) of biotinylated rhCG and two time points
(20 minutes and 40 minutes). To assess the specificity
of hCG binding, parallel cultures of attached cells after
72 hours of culture were incubated with biotinylated
scrambled sham rhCG, unconjugated biotin, unconju-
gated rhCG in place of biotinylated rhCG or without
any of these reagents. The incubation was stopped with
ice-cold PBS, and the cells were fixed in 4% (w/v) para-
formaldehyde to assess the bound hCG by immuno-
fluorescence using an Alexa488-conjugated anti-biotin
monoclonal antibody and a Confocal Laser Scanning
Microscope (DMIRE2, Leica Microsystems, Wetzlar GmbH,
Germany) [24,25].
Multiplex assays of cytokines in conditioned media
The concentrations of 48 cytokines, chemokines and
growth factors (for details, see Additional file 1: Table S1)
that have been reported to be synthesised and secreted by
the human endometrium [21] were analysed. Cell culture
supernatants were assessed by quantitative cytokine assays
using a BioplexTM Pro-human cytokine 27-plex panel and
a cytokine 21-plex panel based on xMAP technology
(Bio-Rad Laboratory, Hercules, CA, USA) according to
the pre-optimised protocol. Briefly, antibody–conjugated
beads were added to individual wells of a 96-well filter
plate and adhered using vacuum filtration. After washing,
50 μl of prediluted standards or serum were added, and
the filter plate was shaken at 300 rpm for 30 minutes
at room temperature. A prediluted multiplex biotin-
conjugated detection antibody was then added for
30 minutes. Prediluted streptavidin-conjugated PE was
added followed by an additional wash and the addition
of Bio-Plex assay buffer. The filter plate was analysed,
and concentrations of each cytokine were determined
using the BioRad BioPlex 200 instrument equipped
with BioManager v6.0 software (Bio-Rad). All samples
were run in duplicate. Standard curves were generated
for each biomarker. Goodness of fit for standard curves
was determined by the standard recovery method and by
calculating the concentration of each standard [26].
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Based on the post-hoc analysis of the immunoassays as
described below, 13 proteins (CCL2, CCL4, FGF2, GMCSF,
IFNG, IL-6, IL-12p35, IL-12p70, LIF, LTA, PDGFbb, TNF
and VEGF) were chosen as target candidates, and their ex-
pression in conditioned medium (n = 3 each) was assessed
in 20 μg protein lysate samples along with the pre-stained
molecular weight marker. Samples were assessed by
SDS-PAGE and subsequent Western immunoblotting
techniques on a nitrocellulose membrane and chemi-
cals obtained from Bio-Rad (Hercules, CA, USA) [24].
The details of the antibodies used are given elsewhere
(see Additional file 2: Table S2). Final visualisation was
achieved using Vectastain ABC immunoperoxidase kits
(Vector Laboratories, Burlingame, CA, USA). Respect-
ive primary and secondary antibody controls were run
simultaneously to examine the specificity of the anti-
bodies. The molecular weights and semi-quantitative
analysis of the bands were determined using densito-
metric equipment (Pharos FX Plus Molecular Imager,
Bio-Rad, Hercules, CA, USA) and optimised densito-
metric analysis software (PD Quest Advanced, Bio-
Rad). The integrated measures of optical densities for
individual antigens were calculated from the log of
transmittance for each target antigen and normalised
to total secreted protein (in micrograms).
Quantitative real time RT-PCR
The relative expression of 17 genes (CCL2, CCL3, CCL5,
CXCL10, FGF2, GCSF, GMCSF, IFNG, IL-1b, IL-6,
IL-13, IL-16, IL-17, LIF, PDGFB, TNF and VEGF) se-
lected as targets from the post-hoc analysis (as de-
scribed below) of the BioPlex cytokine data was
examined. All samples were assessed using glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) as an en-
dogenous control and SYBR Green-based quantitative
RT-PCR as described previously [27]. Briefly, total
RNA was extracted using Trizol (Agilent Technolo-
gies Singapore Pvt. Ltd., Shung Avenue, Singapore),
purified with DNase I (Sigma Chemical Co., St. Louis,
Missouri, USA) and subjected to re-extraction when
necessary. The yield and purity of the extracted RNA
were verified using standard spectrophotometric methods
and 1% agarose gel electrophoresis [27]. Furthermore, the
RIN score of individual samples was determined using the
Agilent 2100 Bioanalyzer, RNA 6000 NanoLabChip kit
and Agilent 2100 Expert Software (Agilent Technologies,
Inc., Santa Clara, CA, USA) [28]. Four samples that failed
to yield either sufficient amounts of RNA or an acceptable
RIN score (>8.0) were not included. For the real time RT-
PCR, the first-strand cDNA was synthesised from 2 μg of
total RNA with an optimised RevertAid™ First Strand
cDNA Synthesis Kit (Fermentas, Germany), and the PCR
was performed using Maxima™ SYBR Green/FluoresceinqPCR Master Mix (Fermentas, Germany) and forward
and reverse primers for the respective genes.
The primers for the target genes were designed using
Beacon Designer software (Labware Scientific Inc., USA)
as shown in Additional file 3: Table S3 and obtained
from Integrated DNA Technologies (Coralville, Iowa,
USA) for target genes. The reaction was performed
on a BioRad platform (iCycleriQTm Real time PCR
detection system, BioRad, Hercules, CA, USA) using
an optimised protocol [27]. Cycle threshold values
were obtained, and ΔCt values between the experimental
and normalised Ct were determined. The relative expres-
sion ratios between groups from cycle threshold (Ct)
values and absolute values were determined as described
previously [27].
Data analysis
Profiles of factors from the immunoassay data were classi-
fied into six scales depending on factor concentrations as
follows (pg per microgram of protein): 0, ≤0.05; 1, >0.05
to 0.1; 2, >0.1 to 1.0; 3, >1.0 to 10.0; 4, >10.0 to 100.0;
5, >100.0. Due to individual variability, data were nor-
malised with the mean basal values from the zero
hCG group as the internal control. The quantitative
values of factors in medium and transcripts in cells
from each culture group with different doses of hCG
were log transformed and analysed using the Kruskal-
Wallis test followed by the Wilcoxon Signed Ranks
test. Significant changes were derived for each bin show-
ing P < 0.05.
Enrichment and process networks analysis
For post-hoc enrichment analysis, candidate products
were matched with known products into functional on-
tologies for ‘common’, ‘similar’ and ‘unique’ sets. The
probability of a random intersection between a candidate
on the target list and ontology entities was estimated in
terms of p-values. A lower p-value meant higher relevance
of the entity to the dataset due to a higher rating for the
entity. Enrichment analyses were performed using a cut-
off threshold (pFDR(p) = 0.05) for the cytokines, chemo-
kines and growth factors showing differential secretion in
response to rhCG to identify the enriched biological path-
ways. Furthermore, the uploaded files of the input list of
cytokines, chemokines and growth factors showing differ-
ential secretion in response to hCG were used for the gen-
eration of biological networks. The Analyze Networks
(AN) algorithm with default settings was used to retrieve
interaction networks that were potentially influenced by
hCG. In this workflow, the networks were prioritised
based on the number of canonical pathways in the net-
work. The enrichment analysis and network constructions
were achieved using a Metacore bioinformatics platform
(GeneGo, St. Joseph, MI, USA) [29].
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Characterisation of isolated cells in culture
The procedure used in the present study yielded >93% viable
cells. Figure 1 (A-L) shows representative microphotographs
of cytokeratin (Figure 1A-C), vimentin (Figure 1D-F), CD45
(Figure 1G-I) and vW factor (Figure 1J-L) localisation in
attached epithelial, stromal and mixed cells 72 hours after
seeding. The washed ‘enriched epithelial cell’ fraction
yielded 88 (±2)% cytokeratin-positive epithelial cells,













Figure 1 Immunocytochemical characterisation of isolated endometri
phase endometrial epithelial cells (A, D, G, J, M, P), stromal cells (B, E, H,
collagen biomatrix and subjected to immunostaining for cytokeratin (green
hCG binding (green; M-O) (detected with biotinylated rhCG) was determine
and non-immune sera from mouse and rabbit (Q) and biotinylated rhCG a
described in the Methods section. Nuclei were counterstained with DAPI (bstromal cell’ population that yielded 92 (±4)% vimentin-
positive stromal cells. Generally, there were no CD45- and
vW factor-positive cells after attachment (Figure 1G-L).
The endometrial mixed cells used in the study typically
constituted 30 (± 4)% cytokeratin-positive epithelial cells
and 70 (±4)% vimentin-positive stromal cells. Figure 1
(M-O) shows the pattern of hCG binding following expos-
ure to biotinylated rhCG (200 mIU/ml) in epithelial cells,
stromal cells and mixed cells at 72 hours in primary cul-







al cell populations in primary culture. Isolated human mid-luteal
K, N, Q) and mixed cells (C, F, I, L, O, R) were allowed to attach to the
; A-C), vimentin (red; D-F), CD45 (green; G-I), vW factor (red; J-L), and
d in each cell type and in non-immune sera from mouse and goat (P)
lone (R) followed by immunofluorescence detection was performed as
lue). Bars = 50 μm.
Table 1 Fold-change (at P < 0.05) observed in secreted
cytokines, chemokines and growth factors from isolated
endometrial cells following administration of
recombinant hCG (100 IU/ml) in three culture groups
Name Groups (Cell type)
1 2 3
(Epithelial) (Stromal) (Mixed)
CCL21 (ι) − −
CCL32 − − (+)8.0
CCL4 (+)1.7 (+)1.55 (+)8.0
CCL52 (+)1.8 − (+)2.8
CCL7 (−)1.7 − −
CXCL1 (−)6.5 − −
CXCL9 − − (−)1.7
CXCL103 − − (+)2.7
CXCL12 (−)2.1 − −
FGF23 − (+)1.5 (+)2.3
GCSF2 − − (+)1.4
GMCSF3 - (+)1.5 (+)2.7
HGF (−)1.6 − (−)1.7
IFNG2 − (+)1.5 (+)2.0
IL-1b1 − (+)2.7 (+)3.3
IL-62 (+)2.1 (−)1.6 (−)2.3
IL-8 − − (−)2.6
IL-12p40 (−)1.5 − −
IL-12p70 - - (ι)
IL-132 - - (+)1.8
IL-161 − (−)2.7 (−)1.8
IL-172 − (+)2.1 -
LIF4 (+)1.5 (+)1.7
MCSF (−)1.5 − (−)1.6
MIF (+)1.7 (−)1.5 (−)2.4
PDGFBB1 − − (ι)
SCGF (−)3.5 − −
TNF2 − − (+)1.7
TRAIL (+)1.5 − (−)1.6
VEGF1 − (+)1.9 (+)2.5
_, no change. (ι), infinitesimally increased because of non-detectable amount
under the basal condition. (), up-regulated. (~) down-regulation. The cytokines
which were subjected to Western blot analysis are shown in bold, and the
ones which were subjected to quantitative real time RT-PCR for estimation of
relative abundance of transcripts are shown in italics.
1did not show significant concordance between immunopositive protein
concentration in medium and relative abundance of transcripts for all cell
culture groups (groups 1–3).
2showed significant (P < 0.05) concordance between immunopositive protein
concentration in medium and relative abundance of transcripts for all cell
culture groups (groups 1–3).
3showed significant (P < 0.05) concordance between immunopositive protein
concentration in medium and relative abundance of transcripts for epithelial
cells (group 1) and mixed cells (group 3), but not for stromal cells (group 2).
4showed significant (P < 0.05) concordance between immunopositive protein
concentration in medium and relative abundance of transcripts for stromal
cells (group 2) and mixed cells (group 3), but not for epithelial cells (group 1).
5no concordance was seen between profiles from multiplex based
immunoassay and from densitometric analysis of Western immunoblot.
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The detailed profile of cytokines secreted from the three
groups of cells under basal conditions (serum-free
DMEM:F12 (1:1) medium supplemented with insulin
(10 μg/ml), transferrin (5.5 μg/ml), selenium (6.7 ng/ml),
hydrocortisone (5 μg/ml), gentamicin (10 μg/ml), penicil-
lin (100 IU/ml), streptomycin (100 μg/ml) and fungizone
(2.5 μg/ml)) is shown in the supplementary table (see
Additional file 4: Table S4). In these conditions, endomet-
rial cells in all three groups secreted more than 1 pg/μg
protein levels of CCL4, CCL5, CXCL9, CXCL12, FGF2,
GMCSF, HGF, IL-2ra, IL-6, IL-12p40, MCSF, MIF, and
VEGF. Additionally, endometrial epithelial cells in group 1
secreted substantial amounts of CCL3, CCL7, CXCL1,
CXCL10, IFNG, IL-1ra, IL-12p70, LIF, PDGFbb and
SCGF; these cytokines were either not detectable or there
was less than 1 pg/μg in the other two groups. CCL2 and
IL-8 were secreted at >1 pg/μg of total secreted protein by
endometrial stromal cells (group 2) and mixed cells
(group 3) but not by endometrial epithelial cells (group 1).
Both endometrial epithelial cells and stromal cells failed to
secrete detectable levels of CCL27, GCSF, IL-2, IL-4, IL-7,
IL-9, IL-10, IL-15, IL-18, bNGF, SCF, and LTA under basal
conditions. Of these twelve cytokines, endometrial mixed
cells did not show detectable levels of seven of the cyto-
kines (CCL27, IL-10, IL-15, IL-18, bNGF, SCF, and LTA)
and had negligible (>0.1 pg/μg protein) amounts of IL-2,
IL-4 and IL-7; however, endometrial mixed cells secreted
substantial amounts of GCSF (>10 pg/μg protein) and
IL-9 (>1 pg/μg protein). Endometrial epithelial cells
did not secrete detectable CCL2, and stromal cells did
not secrete detectable CCL3, CCL7, IL-12p70, IL-13,
PDGFbb, and TNF levels. In endometrial mixed cells,
CCL7, IL-12p70 and PDGFbb were not detectable, and
CCL3, IL-13 and TNF were detectable at very low con-
centrations (<1 pg/μg protein).
Differential cytokine secretion profile following hCG
administration
Statistical analyses failed to identify any significant change
between administration of 0 IU/ml and 1 IU/ml or be-
tween 10 IU/ml and 100 IU/ml of rhCG; however, there
was a significant difference between administration of
0/1 IU and 100 IU of rhCG in group 1 (epithelial cells),
2 (stromal cells) and 3 (mixed cells) cells in the pro-
duction of a large number of cytokines. Table 1 gives a
summary of the fold change in the concentrations of
secreted cytokines as assessed by quantitative multiplex
assays using conditioned media from the three groups of
cells following 100 IU/ml of rhCG treatment.
Immunochemical and transcript analyses
Marked concordance was observed between estimates
of changes in concentrations obtained from multiplex
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teen cytokines. An exception was CCL4 in the condi-
tioned media of stromal cells in which a positive
significant change following 100 IU of hCG administra-
tion was demonstrated in multiplex assays, but no detect-
able change was observed in the Western immunoblot
analysis (Table 1). Figure 2 shows representative Western
blot images for the cytokines with significant changes in
expression (P < 0.05).
On the other hand, the expression of seventeen genes
based on quantitative real time RT-PCR revealed marked
variation between changes in protein secretory profiles
and the relative abundance of transcripts in the cells fol-
lowing treatment with rhCG (100 IU/ml). Figure 3
shows a graphical comparison of the changes observed
in cytokine protein levels in the conditioned media and
in the relative abundance of transcripts of these cytokines,
chemokines and growth factors in the cultured cells; the
data demonstrated a significant increase in the cytokine
transcript levels following treatment with 100 IU rhCG
compared with that in the basal condition.
Enrichment analysis and biological networks construction
Table 2 shows the summary of the enrichment analysis
for the candidate cytokines, chemokines and growth fac-
tors showing differential (≥1.5) secretion at P < 0.05 fol-
lowing the administration of hCG in all three cellFigure 2 Representative Western blot analysis of selected
cytokines. Immunopositive images of CCL2, GMCSF, IL-6, LIF,
PDGFBB and VEGF in conditioned media with isolated human endo-
metrial epithelial cells (Group 1), stromal cells (Group 2) and mixed
cells (Group 3) treated without or with rhCG (100 IU/ml) are shown.
Conditioned media from different groups (20 μg of protein deter-
mined by Bradford assay) were subjected to electrophoretic separ-
ation followed by immunoblot analysis. The relative optical densities
were measured by integrated image analysis per μg of protein.culture groups. The integral modules that were affected
by hCG treatment were immune response, chemotaxis,
inflammatory changes, proliferation, cell adhesion and
anti-apoptosis. It is notable that the hierarchical analysis
of pathways and GO processes indicated a differential
behaviour among epithelial, stromal and mixed cells
upon treatment with hCG (Table 2).
Discussion
The cells in the three culture groups showed differential
profiles of cytokine, chemokine and growth factor secre-
tion in the present study. Table 3 provides a summary of
the unique secretory profiles observed in the different
experimental groups. It appears that the multiplexed
method of simultaneous immunoassay analysis is robust,
as the profiles generally concurred well with the profiles
determined by Western blot analysis. The observed mis-
match in cytokines was probably due to differences ei-
ther in sensitivities (CCL2, PDGFbb) or target epitopes
(IL-1b and VEGF) between the two immunochemical
methods. Furthermore, the three-dimensional primary
culture model in conjunction with large-scale assays is a
robust model system to study the endocrine, paracrine
and juxtacrine aspects of the complex regulation of
implantation-stage endometrial cells as suggested by
other groups [30,31].
Cell type specificity of secretory profiles under basal
conditions
Although CCL4, CCL5, CXCL9, CXCL12, FGF2, GMCSF,
HGF, IL-2ra, IL-6, IL-12p40, MCSF, MIF and VEGF were
observed to be consistently produced by all cells types, cell
type specificity without the addition of hCG was evident.
Endometrial epithelial cells showed a markedly different
secretory profiles as compared with stromal cells; for
example, the concentrations of CCL3, CCL7, CXCL1,
CXCL10, IFNG, IL-1ra, IL-12p70, LIF, PDGFbb, and
SCGF were much higher in the conditioned media of
endometrial epithelial cells as compared with that of stro-
mal cells, whereas the concentrations of CCL2 and IL-8
were much higher in the conditioned media of endomet-
rial stromal cells as compared with that of epithelial cells.
Clearly, epithelial cells secreted multiple cytokines.
As expected, there were marked similarities in the
secretory profiles of most of the cytokines, chemokines
and growth factors between homologous endometrial
epithelial cells or stromal cells and heterologous mixed
cells comprised of endometrial epithelial (≈30%) plus
stromal cells (≈70%). However, two mediators showed
differential profiles, GCSF and IL-9; although these fac-
tors were absent in the conditioned media of both endo-
metrial epithelial cells and stromal cells, they were
secreted in substantial amounts by mixed cells in heter-
ologous culture. A high level of GCSF secretion only by
Figure 3 Bar diagram showing fold increase in protein and transcript levels from cells treated in vitro with and without hCG. Fold
increase in protein levels between cultures treated without or with rhCG (100 IU/ml) in conditioned media (grey bar) and relative abundance of
transcripts (black bar) in cultured (A) endometrial epithelial cells, (B) endometrial stromal cells, and (C) endometrial mixed cells are shown. The
pattern of regulation by hCG depending on cell type and cytokine is evident. For example, the protein level of CCL2 is high but shows very little
change at the transcript level, whereas levels of IL-6 at both the protein and transcript level are high following rhCG treatment only in epithelial
cells (A). Similarly, the protein levels of FGF2 and GMCSF are high but show very little change at the transcript level in stromal cells (B), whereas
both protein and transcript levels are high in the mixed cells (C); these cytokines were unaffected in epithelial cells following hCG treatment. The
pattern of changes in IFNG gene expression and protein secretion is very similar between endometrial stromal cells (B) and endometrial mixed
cells (C) following administration of hCG.
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paracrine function of the endometrium in view of the re-
ported positive action of GCSF on endometrial stromal
cells and growth for embryo implantation [32,33]. Many
of the cytokines that were secreted by endometrial cells
in basal culture conditions are known to be present in
human endometrial cells and uterine fluid and directly
and indirectly influence endometrial receptivity and em-
bryo implantation [14,34-38].
Cell type-specific differential responses to hCG
Many of the cytokines, chemokines and growth factors
were differentially secreted in the medium following ad-
ministration of recombinant hCG (100 IU/ml), especially
from endometrial epithelial cells and mixed endometrial
cells. It is notable that an hCG level of 100 IU/ml ap-
pears in the circulation during the first 7 weeks of preg-
nancy and that there is no allometric algorithm to
determine the local level of hCG; thus, a significant
modulatory effect of intraluminal administration of hCGcould be recorded only at 500 IU/ml [10,39]. Further-
more, the fact that there is a discernable difference in
the cellular physiology of in vivo versus in vitro mamma-
lian cells is well acknowledged [19,22,23]. Thus, we be-
lieve that the dosage for effective hCG (100 IU/ml)
action may be specific to the in-vitro experimental
model.
Many of the cytokines, chemokines and growth factors
that were affected by hCG in the present study have also
been reported to be influenced by hCG in the human
endometrium in different experimental models as shown
in Table 4. On the other hand, to our knowledge, this is
the first report identifying the increased secretion of
CCL3 (MIP-1a), CCL4 (MIP-1b), CCL5 (RANTES),
IFNG, IL-13, PDGFbb and TRAIL and the decreased se-
cretion of CCL7 (MCP-3), CXCL1 (GRO-a), CXCL9
(MIG), CXCL12 (SDF-1), HGF (SOS), IL-8, IL-16 and
SCGF by mid-luteal phase endometrial cells following
the in vitro administration of hCG. However, there are
several reports indicating that many of these cytokines,
Table 2 Summary of top scored features retrieved from reports of enrichment analysis from input list of cytokines,
chemokines and growth factors showing high basal secretion and/or differential secretion following administration
of hCG
Enrichment by Types of cell culture
Epithelial cells Stromal cells Mixed cells
(Active products) (Active products) (Active products)
[pValue; FDR] [pValue; FDR] [pValue; FDR]
Pathway maps Immune response Immune response Immune response
(CCL2, CCL4, CCL5, CCL7, XCL1, IL-6,
IL-12, HGF)
(CCL4, GMCSF, IFNG, IL-1b, IL-6, IL-17,
MIF, VEGF)
(CCL3, CCL4, CCL5, GCSF, GMCSF, HGF,
IFNG, IL-1b, IL-6, MIF, TNF, VEGF)
[8.3E-08; 1.6E-05] [8.7E-08; 8.5E-06] [1.9E-09; 4.3E-07]
Macropinocytotic transport Epithelial-mesenchymal transition
(HGF, MCSF) (FGF2, HGF, IL-1b, TNF)
[1.2E-05; 5.7E-04] [7.9E-05; 1.7E-05]
GO process Chemotaxis, leukocyte chemotaxis Chemotaxis, leukocyte chemotaxis Regulation of response to stimulus, signal
transduction and cell communication
(CCL2, CCL3, CCL4, CCL5, CCL7, CXCL1,
CXCL12, HGF, IL-6, MIF)
(CCL4, IFNG, IL-1b, IL-6, IFNG, MIF,
VEGF)
(CCL4, CCL5, CXCL12, FGF2, GCSF, GMCSF,
HGF, IL-13, LIF, MCSF, MIF, TNF, VEGF)
[9.9E-21; 7.9E-18] [2.0E-15; 3.2E-12] [1.8E-27; 3.7E-24]
Regulation of response to stimulus Chemotaxis, leukocyte chemotaxis
(CCL4, FGF2, IL-1b, IL-6, IL-17 VEGF) (CCL3, CCL4, CCL5, CXCL12, FGF2, HGF, IFNG,
IL-1b, IL-6, MIF)
[8.4E-14; 4.6E-11] [5.2E-22; 2.8E-19]
Immune response
(CCL3, CCL4, CCL5, CXCL9, CXCL10, GCSF,





Inflammation Immune response Inflammation
(CCL2, CCL3, CCL4, CCL5, CCL7, CXCL12,
HGF, IL-6, IL-12, LIF, MCSF)
(GMCSF, IL-1b, IL-6, IL-17, MIF) (CCL3, CCL5, GCSF, GMCSF, IFNG, IL-6, IL-13,
LIF, MCSF, TNF)
[2.9E-09; 2.4E-07] [4.9E-09; 3.2E-07] [9.6E-13; 9.3E-11]
Chemotaxis Signal transduction
(CCL2, CCL3, CCL4, CCL5, CCL7, CXCL1,
CXCL12)
(GMCSF, IFNG, IL-1b, VEGF)
[5.7E-09; 2.4E-07] [9.9E-06; 3.1E-04]
Chemotaxis Signal transduction Proliferation
(CCL2, CCL3, CCL4, CCL5, CCL7, CXCL1,
CXCL12)
(GMCSF, IFNG, IL-1b, VEGF) (CXCL12, FGF2, GCSF, GMCSF, HGF, LIF, VEGF)
[5.7E-09; 2.4E-07] [9.9E-06; 3.1E-04] [6.6E-12; 3.2E-10]
Immune response Inflammation Cell adhesion
(CXCL12, CCL2, CXCL1, IL-6, CCL7, MIF) (IL-1b, GMCSF, IFNG, CCL4, IL-6) (IL-1b, TNF, CCL3, VEGF, MIF, FGF2, CCL5,
CCL4, CXCL12)
[1.5E-08; 2.4E-07] [1.5E-06; 3.1E-04] [3.3E-10; 1.1E-08]
Cell adhesion Anti-apoptosis Chemotaxis
(CCL2, CCL3, CCL4, CCL5, CCL7, CXCL1,
CXCL12)
(FGF2, GMCSF, IL-1b, IL-6, VEGF) (CCL3, CCL4, CCL5, CXC12, FGF2, IL-1b, MIF,
VEGF)
[1.4E-08; 2.9E-06] [2.3E-05; 3.7E-04] [9.4E-10; 2.3E-08]
Proliferation Cell adhesion Anti-apoptosis
(CCL4, CCL5, CXCL12, HGF, IL-12) (FGF2, IL-1b, IL-6, VEGF) (CCL3, FGF2, GMCSF, HGF, IL-1b, IL-6,
TNF, VEGF)
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Table 2 Summary of top scored features retrieved from reports of enrichment analysis from input list of cytokines,
chemokines and growth factors showing high basal secretion and/or differential secretion following administration
of hCG (Continued)
[2.4E-07; 4.1E-06] [1.4E-04; 1.0E-03] [5.8E-09; 9.4E-08]
Immune response
(GCSF, GMCSF, IL-1b, IL-6, MIF)
[5.2E-08; 6.3E-07]
FDR false discovery rate.
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metrium may be regulated by various paracrine mediators,
such as INFG, IL-1, IL-6, PAF, thrombin and TNF, which
are potentially secreted from implantation-stage endomet-
rium and the embryo [40-52]. We observed that hCG could
influence the secretion of many of these paracrine media-
tors (INFG, IL-1b, IL-6, and TNF) by implantation-stage
endometrium. Furthermore, some of the cytokines, chemo-
kines and growth factors (CCL3, CCL4, CCL5, FGF2,
GCSF, GMCSF, IL-1b, IL-6, IL-8, LIF, PDGFbb, TNF and
VEGF) that were found to be differentially regulated by
hCG in endometrial cells are known to have direct or indir-
ect action in supporting embryo implantation [33,53-55],
and indeed a few (CCL2, CXCL10, IL-1b and TNF) have
shown significant correlation with successful implantation
and establishment of clinical pregnancy [56].
CG may control the endometrial informational networks
that promote receptivity
The results obtained in the present study strongly cor-
roborate the notion that hCG influences the physiologyTable 3 Summary of the major observations from the presen
(Description) Group Concentration level of secretion
(pg in μg protein) in basal condition
Group 1 ≤1








Group 3 ≤1 C
(Endometrial mixed cells) >1-10 CC
>10-100
>100
(+), up-regulated. (−), down-regulated.
The cytokines, chemokines and growth factors which were regulated in cell culture
1≥ 1.5-fold at P < 0.05.of the endometrium and embryo during the time of
blastocyst implantation. Based on a large number of pre-
vious reports [21,32-80], we have constructed a tentative
model of the hCG-mediated paracrine activity control-
ling implantation of the embryo and the endometrium
(Figure 4). It is apparent that several embryotropic cyto-
kines, chemokines and growth factors, which include
CCL3, CCL4, CCL5, CXCL10, FGF2, GMCSF, IFNG, IL-
1b, IL-6, IL-13, LIF, PDGF, TNF and VEGF, were up-
regulated in implantation-stage endometrium by hCG.
Furthermore, several of these cytokines are known to
regulate stromal fibroblasts (e.g., FGF2, GCSF, GMCSF,
IFNG, IL-1b, IL-6, LIF, MIF, TNF and TRAIL), vascular
physiology (e.g., CCL2, CXCL10, GMCSF, IL-1b, IL-6,
LIF, MIF, PDGFbb, TNF and VEGF) and glandular physi-
ology (e.g., LIF, MIF, PDGFbb, and TNF). Many of these
factors directly and indirectly regulate the function of
immunocompetent cells. Thus, CG may affect endomet-
rial functions related to inflammation, differentiation,
proliferation, apoptosis, immune surveillance and im-
mune tolerance through the production of a set oft study
Name of cytokines showing differential1 secretion following
administration of hCG
CCL2 (+), TRAIL (+)
CL5 (+), CCL7 (−), CXCL12 (−), HGF (−), IL-12p40 (−), LIF (+), MCSF (−)
CCL4 (+), CXCL1 (−), MIF (+), SCGF (−)
IL-6 (+)
IL1b (+), IL-16 (−), IL17 (+)
CCL4 (+), FGF2 (+), IFNG (+), IL-6 (−), VEGF (+)
GMCSF (+), MIF (−)
None
CL3 (+), CXCL10 (+), IL-1b (+), IL-12p70 (+), IL-13 (+), IL-16 (−), LIF (+),
PDGFbb (+), TNF (+), TRAIL (−)
L4 (+), CCL5 (+), CXCL9 (−), FGF2 (+), GMCSF (+), HGF (−), IFNG (+), MCSF (−)
GCSF (+), IL-8 (−), MIF (−), VEGF (+)
IL-6 (−)
group specific manner are shown in bold.
Table 4 A summary of the results from the present study and previous reports for common endometrial secretions
observed to be affected by hCG
Name Observation in the present
study; affected cell culture
type
Observation in the previous
studies; experimental model
[Reference]
Putative function in implantation process [Reference]
CCL2 Increase: epithelial HEnC No change; mixed endometrial cells1
[45]
Regulation of angiogenic and immunotolerant environment
[57,58]
CXCL10 Increase; mixed HEnC Increase; HEEC1 [14] Regulation of NK cell recruitment and angiogenesis [59,60]
FGF2 Increase; stromal HEnC and
mixed HEnC
Increase; HEEC1[14] Regulates endometrial stromal cell proliferation and receptivity
and embryo growth, attachment and trophoblast function
[61,62]
GMCSF Increase; stromal HEnC and
mixed HEnC
Increase; HEEC1[14] Regulates endometrial stromal cells, leukocytes and capillaries
along with embryotropic action [34,53,63]
IL-1b Increase; stromal HEnC and
mixed HEnC
Increase; intrauterine secretion2 [39] Mediates endometrial preparation for implantation [36,58]




IL-6 Increase; epithelial HEnC
Decrease; stromal HEnC and
mixed HEnC
Increase; intrauterine secretion2 [39] Regulates hCG secretion by trophoblast cells and endometrial
development [36,65,66]
Increase; mixed endometrial cells1
[67]
Decrease; HEEC1 [7]
No change; HEEC1 [14]
IL-12 Decrease (p40); epithelial HEnC Endometrial secretion aspiration3 [64] Regulates NK cell function and mediates cell mediated immunity
[68]
Increase (p70); mixed HEnC
IL-17 Increase; stromal HEnC Increase; endometrial secretion
aspiration3 [64]
Potentially regulates chemokines and cytokines networks [69]
LIF Increase; epithelial HEnC and
mixed HEnC
No change; mixed endometrial cells1
[67]
Supports endometrial receptivity and embryo development [36]
Increase; intrauterine secretion2 [39]
Increase; HEEC1 [7,14]
MCSF Decrease; epithelial HEnC and
mixed HEnC
Decrease; intrauterine secretion2 [39] Paracrine regulation of stromal decidualization under
progesterone dominance [70,71]
MIF Increase; epithelial HEnC and
mixed HEnC
Increase; endomerial stromal cells1 [9] Paracrine regulation of immunomodulation, angiogenesis and
growth [47,72]
Decrease; stromal HEnC
TNF Increase; mixed HEnC Increase; mixed endometrial cells1
[64]
Regulates balance of cytokine, chemokines and growth factors
towards endometrial and embryo development [73,74]
Increase; endometrial secretion
aspiration3 [39]
VEGF Increase; stromal HEnC and
mixed HEnC
Increase; intrauterine secretion2 [39] Regulates endometrial angiogenesis, permeability receptivity and
embryo development [36,75,76]
Increase; HEEC1 [7,14,77]
Increase; mixed endometrial cells1
[78]
Increase; epithelial HEnC [25]
HEnC, endometrial cells in primary culture on collagen biomatrix. HEEC, isolated human endometrial epithelial cells. HEExC, human endometrial explant culture.
1Conventional primary culture.
2Intrauterine microdialysis. 3endometrial secretion aspired on the day of embryo transfer in stimulated cycle in IVF-ET and compared with that in natural cycle.
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time of blastocyst implantation. Additionally, hCG influ-
ences macropinocytic transport in epithelial cells, regulates
responses to external stimuli in stromal cells and promotes
epithelial-mesenchymal transition in mixed cells. These arewell-known biological features of implantation-stage endo-
metrial tissue [79]. Further networks analysis in determin-
ing the hierarchy of different functional processes revealed
that the regulation of inflammation, proliferation, cell
adhesion, chemotaxis, apoptosis and immune response
AB
Figure 4 A proposed model of the paracrine action mediated
by hCG that involves different cell types in the endometrium
and that affects the implantation-stage embryo and endomet-
rium. The pre-implantation embryo- and endometrium-derived CG
may specifically act on endometrial surface epithelium alone (A) or
may act on both the endometrial epithelial cells and stromal fibro-
blasts (B), resulting in up-regulation of a specific cohort of cytokines,
chemokines and growth factors. Many of these factors (e.g., CCL3,
CCL4, CCL5, CXCL10, FGF2, GMCSF, IFNG, IL-1b, IL-6, IL-13, LIF,
PDGFb, TNF and VEGF) are reportedly embryotropic, some (e.g., IL-6
and LIF) are primarily secreted by endometrial epithelial cells, and a
few (e.g., FGF2, GMCSF, INFG, IL-1b and VEGF) are secreted primarily
by endometrial fibroblasts in response to hCG. In contrast, many of
the secreted factors are known to regulate stromal fibroblasts (e.g.,
FGF2, GCSF, GMCSF, IFNG, IL-1b, IL-6, LIF, MIF, TNF and TRAIL), vascu-
lar physiology (e.g., CCL2, CXCL10, GMCSF, IL-1b, IL-6, LIF, MIF,
PDGFb, TNF and VEGF) and glandular physiology (e.g., LIF, MIF,
PDGFb, and TNF). Only a few of the factors (e.g., CCL2, IL-6, LIF and
MIF) are secreted by isolated endometrial epithelial cells in response
to hCG. Interestingly, many of these factors directly and indirectly
regulate the functions of immunocompetent cells. A large number
of reports [21,32-53,57-78,80] and the results of the present study
have been used to develop this model. BV (blood vessel), FB (fibro-
blast), GL (gland), IC (immunocompetent cells), PIE (pre-implantation
embryo). There is no quantitative aspect to the length and thickness
of arrows.
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endometrium.
In general, administration of CG can influence the
function of the endometrium during embryo implant-
ation. There are at least three aspects of CG-regulated
endometrial informational networks that may further be
examined to elucidate its potential involvement in the
implantation process. First, studies are required to
understand the mechanism by which CG regulates the
above-mentioned physiological modules, namely inflam-
mation, proliferation, cell adhesion, chemotaxis, apoptosis
and immune response, on the background of proges-
terone dominance in endometrial cells during implant-
ation. Secondly, further studies are necessary to unravel
how CG could exert differential effects on transcript and
protein levels at the steady state depending on cell type
and cytokine as revealed in the present study. A large
number of reports indicate that manifestation of such
poor correlations suggests multi-level regulation by an in-
put signal [81-84], which was hCG in this study. Thirdly,
additional multi-scale and multi-level studies are necessary
to understand the CG-mediated regulation of endometrial
functions at implantation that involve paracrine control
between cell types.
Conclusions
Several interesting points may be concluded from the re-
sults of the present study. First, the primary cell culture
of human endometrial cells on collagen biomatrix is a
robust experimental model to study the endocrine, para-
crine and juxtacrine actions of a biological molecule,
hCG. Despite the fact that there were several cytokines,
chemokines and growth factors commonly secreted by
isolated endometrial epithelial cells, stromal cells and
mixed cells under basal conditions, there were many cy-
tokines that were secreted specifically by endometrial
epithelial cells. However, a substantial level of GCSF was
produced by endometrial cells only when epithelial and
stromal cellular elements were mutually interactive. Thus,
GCSF appears to be a potential physiological marker of
the functional integrity of the endometrium. Furthermore,
it was demonstrated for the first time that administration
of hCG could affect isolated endometrial epithelial cells,
stromal cells and mixed cells in a differential fashion.
Many of the factors are known to exert paracrine influ-
ence on implantation-stage endometrium (e.g., IFNG,
IL-1b, IL-6 and TNF) and support embryo implant-
ation (e.g., CCL3, CCL4, CCL5, FGF2, GCSF, IL-1b,
IL-6, IL-8, LIF, PDGFbb, TNF and VEGF) through
their regulatory actions on inflammation, proliferation,
cell adhesion, chemotaxis, apoptosis and immune re-
sponses during blastocyst implantation. It is thus apparent
that embryo- and endometrial-derived CG can influence
implantation-stage endometrial functions through complex
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http://www.rbej.com/content/11/1/116processes involving various cell types in the endometrium.
Finally, this study provided a panel of specific cytokines,
chemokines and growth factors that are secreted by
various cell types in the endometrium during the window
of implantation.
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